Check if the document is available in the language of your choice. With an HPE Synergy composable infrastructure platform and HPE ProLiant DL380 Gen10 cluster, the Netherlands Cancer Institute-Antoni van Leeuwenhoek (NKI-AVL) is accelerating research and enhancing efficiency for clinicians. As a result, the high-performance, highly flexible HPE infrastructure is helping NKI-AVL advance discoveries of new cancer treatments and enabling physicians and nurses to spend more focused time on patient care. HPE COMPOSABLE INFRASTRUCTURE PLATFORM FUTURE-PROOFS IT AT NETHERLANDS CANCER INSTITUTE HPE Synergy and HPE ProLiant DL380 speed research, drive efficient care Industry Healthcare Objective Improve IT agility and performance to support demanding research projects and dynamic cl

Join for free to read